Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Temozolomide 2 Specimen Handling 2 Rituximab 2 Radiotherapy 2 Radiosurgery 2 Paclitaxel 2 Neoadjuvant Therapy 2 Gemcitabine 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 venetoclax 1 theanine 1 temsirolimus 1 tafasitamab 1 sugemalimab 1 senicapoc 1 sacituzumab govitecan 1 ruxolitinib 1 perampanel 1 paricalcitol 1 pamiparib 1 olaparib 1 lutetium Lu 177 dotatate 1 irinotecan sucrosofate 1 glofitamab 1 gadobutrol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × perampanel × 30 days × Clear all

NCT07284069 2026-05-07

SENIPERA

University of Aarhus

Phase EARLY_PHASE1 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡